Suppr超能文献

变异型遗传性血管性水肿表型对达那唑治疗的反应。遗传学意义。

Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications.

作者信息

Gadek J E, Hosea S W, Gelfand J A, Frank M M

出版信息

J Clin Invest. 1979 Jul;64(1):280-6. doi: 10.1172/JCI109449.

Abstract

Hereditary angioedema (HAE), an auto-somal dominant disorder characterized by attacks of episodic edema is associated with decreased functional levels of the C1 esterase inhibitor. Approximately 85% of patients have lowered antigen levels of a normal inhibitor protein. 15% of patients have normal or elevated antigenic levels of functionless protein. We have examined the response to danazol therapy of patients with the variant HAE phenotypes possessing the abnormal protein in an effort to determine if these patients possess a normal structural C1 inhibitor allele. Four patients with a variant HAE phenotype were treated successfully with danazol. In two patients, distinguished by the presence of a functionless, albumin-bound, C1 inhibitor (phenotype 2), phenotypic analysis of the danazol response by bidirectional immunoelectrophoresis revealed the appearance of the normal C1 inhibitor gene product during danazol therapy. This relatively cathodal C1 inhibitor peak appears in conjunction with the development of nearly normal functional activity. All of the functional C1 inhibitory activity which appeared in the phenotype 2 treatment serum was associated with the electrophoretically normal inhibitor. This normal protein could be separated from the functionless inhibitor protein by immunoadsorption and molecular sieve chromatography. Danazol therapy of the two patients with an electrophoretically normal, functionless C1 inhibitor (phenotype 3) also resulted in a clinical remission associated with development of a significant increment in functional serum C1 inhibitory activity and C1 inhibitor protein. These findings demonstrate that these two HAE phenotypic variants are heterozygous for the normal serum C1 inhibitor, a finding which was not apparent before phenotypic analysis of this serum during danazol therapy. These data provide strong evidence for a basic similarity between the common form of HAE and its phenotypic variants. They also suggest that a structural gene lesion may result in the abnormalities of serum C1 inhibitor function and disease expression in all three of these HAE phenotypes.

摘要

遗传性血管性水肿(HAE)是一种常染色体显性疾病,其特征为发作性水肿,与C1酯酶抑制剂功能水平降低有关。约85%的患者正常抑制蛋白的抗原水平降低。15%的患者无功能蛋白的抗原水平正常或升高。我们研究了具有异常蛋白的变异型HAE表型患者对达那唑治疗的反应,以确定这些患者是否拥有正常结构的C1抑制剂等位基因。4例变异型HAE表型患者成功接受了达那唑治疗。在2例以存在无功能的、与白蛋白结合的C1抑制剂为特征的患者(表型2)中,通过双向免疫电泳对达那唑反应进行表型分析发现,在达那唑治疗期间出现了正常的C1抑制剂基因产物。这个相对向阴极移动的C1抑制剂峰与几乎正常的功能活性的发展同时出现。表型2治疗血清中出现的所有功能性C1抑制活性都与电泳正常的抑制剂有关。这种正常蛋白可以通过免疫吸附和分子筛色谱与无功能的抑制剂蛋白分离。对2例电泳正常但无功能的C1抑制剂患者(表型3)进行达那唑治疗,也导致了临床缓解,同时功能性血清C1抑制活性和C1抑制剂蛋白显著增加。这些发现表明,这两种HAE表型变异体对于正常血清C1抑制剂是杂合的,这一发现在达那唑治疗期间对该血清进行表型分析之前并不明显。这些数据为HAE常见形式与其表型变异体之间的基本相似性提供了有力证据。它们还表明,结构基因损伤可能导致所有这三种HAE表型的血清C1抑制剂功能异常和疾病表现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验